(4-(N,N-Diethylsulfamoyl)phenyl)boronic acid, 97%, 250mg

N -[3-(2-Amino-thiazol-4-yl)-phenyl]-acetamide, 95+%, 1g

tert-butyl {[(4-methylphenyl)sulfonyl]oxy}carbamate, 95.0%, 1g

1-Bromo-4-(2,2-difluorovinyl)benzene, 95% (stabilized with TBC), 1g

2-CHLORO-3,4-DIFLUOROBENZYL ALCOHOL, 95.0%, 5g

N-[(1S,2S)-2-Amino-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzenesulfonamide, 97%, 5g

2-(TERT-BUTYL)PYRIMIDIN-4(3H)-ONE, 95.0%, 1g

Nimustine hydrochloride, 97%, 5g

Benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95%, 100mg

4-(Methoxycarbonyl)-2-(trifluoromethyl)phenylboronic acid, 97%, 250mg

2-(2-(1,3-Dioxolan-2-yl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

4-Oxo-cyclohexanecarbonitrile, 95.0%, 1g

Pipetas volumétricas 1 marca clase B, 10 ml, 6 piezas